ADVANCED ENZYME TECHNOLOGIES
Back to Balance Sheet
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹1,611 Cr | ₹1,521 Cr | ₹1,411 Cr | ₹1,260 Cr | ₹1,149 Cr |
What is the latest Total Liabilities ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹1,611 Cr |
| Mar2024 | ₹1,521 Cr |
| Mar2023 | ₹1,411 Cr |
| Mar2022 | ₹1,260 Cr |
| Mar2021 | ₹1,149 Cr |
How is Total Liabilities of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,611 Cr | 5.91 | |
| Mar2024 | ₹1,521 Cr | 7.85 | |
| Mar2023 | ₹1,411 Cr | 11.93 | |
| Mar2022 | ₹1,260 Cr | 9.65 | |
| Mar2021 | ₹1,149 Cr | - | |
Compare Total Liabilities of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹3,009.6 Cr | -2.4% | -12% | -20% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | -2.4% |
-12% |
-20% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses